Skip to main content
. 2024 Mar 9;19:421–437. doi: 10.2147/CIA.S449338

Table 1.

Comparison of Clinical Information Between Training Set and Validation Set((n(%)) or Cases/%)

Variables Training Set (n=243) Validation Set(n=104) Z/χ2 P value
Age (years) 80.000(74.00, 86.00) 78.000(74.00, 84.00) −1.304 0.192
BMI (kg/m2) 19.835(18.80, 21.10) 19.678(19.00, 21.60) −0.505 0.613
WBC (10^9/L) 5.450(4.00, 7.20) 5.850(4.30, 7.70) −1.157 0.247
Neutrophil granulocyte (10^9/L) 3.760(2.80, 5.30) 3.960(3.00, 5.70) −0.932 0.352
Lymphocyte (10^9/L) 1.020(0.70, 1.40) 1.075(0.70, 1.50) −0.822 0.411
CRP (mg/L) 4.390(1.20, 24.10) 8.780(1.90, 24.70) −1.642 0.101
D-dimer (ug/L) 0.560(0.30, 1.30) 0.645(0.30, 1.30) −0.624 0.533
Hb (g/L) 116.000(102.00, 124.00) 116.000(104.50, 123.80) −0.314 0.753
Scr (umol/L) 77.900(62.30, 97.80) 70.650(56.40, 91.70) −1.701 0.089
ALB (g/L) 34.900(32.90, 36.10) 34.950(33.50, 36.00) −0.037 0.970
AST (%)
≤35 158(65.02) 69(66.35) 1.755 0.625
35<AST≤105 77(31.69) 31(29.81)
105<AST≤175 3(1.23) 3(2.88)
>175 5(2.06) 1(0.96)
ALT (%)
≤40 167(68.72) 76(73.08) 2.255 0.521
40<AST≤120 68(27.98) 27(25.96)
120<AST≤200 4(1.65) 1(0.96)
>200 4(1.65) 0(0.00)
Gender (%)
Male 133(54.73) 54(51.92) 0.231 0.631
Female 110(45.27) 50(48.08)
GNRI (%)
<82 26(10.70) 7(6.73) 1.607 0.448
82≤GNRI<92 148(60.91) 69(66.35)
92≤GNRI<98 69(28.40) 28(26.92)
Mid-arm circumference (%)
<21 21(8.64) 8(7.69) 1.107 0.575
21≤Mid-arm circumference<22 92(37.86) 34(32.69)
≥22 130(53.50) 62(59.62)
Gastrocnemius circumference (%)
<31 72(29.63) 24(23.08) 1.563 0.211
≥31 171(70.37) 80(76.92)
Cerebral infarction (%)
No 143(58.85) 68(65.38) 1.306 0.253
Yes 100(41.15) 36(34.62)
Renal failure (%)
No 218(89.71) 94(90.38) 0.036 0.849
Yes 25(10.29) 10(9.62)
Tumour (%)
No 215(88.48) 95(91.35) 0.629 0.428
Yes 28(11.52) 9(8.65)
Pneumonia (%)
No 195(80.25) 76(73.08) 2.189 0.139
Yes 48(19.75) 28(26.92)
Chronic obstructive pulmonary disease (%)
No 181(74.49) 79(75.96) 0.084 0.771
Yes 62(25.51) 25(24.04)
Type 2 diabetes (%)
No 167(68.72) 70(67.31) 0.068 0.795
Yes 76(31.28) 34(32.69)
Coronary disease (%)
No 166(68.31) 77(74.04) 1.138 0.286
Yes 77(31.69) 27(25.96)
Hypertension (%)
No 105(43.21) 39(37.50) 0.978 0.323
Yes 138(56.79) 65(62.50)
Skin ulcer (%)
Yes 78(32.10) 26(25.00) 1.749 0.186
No 165(67.90) 78(75.00)
Protein intake (%)
Less 49(20.16) 17(16.35) 1.157 0.763
Commonly 92(37.90) 42(40.38)
More 102(41.94) 45(43.27)
History of drinking (%)
No 127(52.26) 56(53.85) 0.073 0.787
Yes 116(47.74) 48(46.15)
Intake of vegetables and fruits (%)
Less than twice a day 121(49.79) 51(49.04) 0.017 0.897
Twice or more a day 122(50.21) 53(50.96)
Diet status in recent 3 months (%)
Severe loss of appetite 17(7.00) 7(6.73) 6.204 0.102
Moderate loss of appetite 77(31.69) 21(20.19)
Mild loss of appetite 73(30.04) 43(41.35)
No 76(31.28) 33(31.73)
Activity situation (%)
Bed-ridden or long-term seated person 63(25.93) 22(21.15) 1.231 0.540
Can leave the bed or table and chair, but can not go out 103(42.39) 50(48.08)
Can go out on your own 77(31.69) 32(30.77)
Nervous and psychological problems (%)
Severe dementia or depression 26(10.70) 10(9.62) 0.220 0.896
Mild dementia 62(25.51) 25(24.04)
No psychological problems 155(63.79) 69(66.35)
History of smoking (%)
No 152(62.55) 64(61.54) 0.032 0.858
Yes 91(37.45) 40(38.46)
Vaccination (%)
No 68(27.98) 19(18.27) 6.056 0.109
Potion 124(51.03) 58(55.77)
Two doses 36(14.81) 23(22.12)
Three doses 15(6.17) 4(3.85)

Abbreviations: BMI, body mass index; WBC, white blood cell count; CRP, c-reactive protein; Hb, hemoglobin; Scr, serum creatinine; ALB, albumin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GNRI, geriatric nutritional risk index.